What's the age range in polivy patient studies?

Polivy (polatuzumab vedotin) studies have been conducted in adults only. Inclusion criteria across trials typically start at age 18, with no pediatric data published to date. The exact upper age limit varies by study, but many trials include patients up to the mid‑80s or 90s depending on eligibility.

If you have a specific study or NCT number in mind, tell me and I’ll pull the exact age range from that trial’s inclusion criteria.